Advancements in Treating Hepatitis C

Three to four million Americans are infected with Hepatitis C, a blood borne virus that affects the liver. Having become the most common blood-borne virus, the effect of Hepatitis C on the liver has made it the number one reason for liver transplantation in the U.S., and is also responsible for the rising incidence of liver cancer. Fortunately, Hepatitis C is curable, thanks to recent therapeutic advancements. In this video, Dr. Paul Kwo—Gastroenterologist and Hepatologist at IU Health and Professor of Medicine at the Indiana University School of Medicine—highlights the effectiveness of new treatments available for Hepatitis C and speaks to the ongoing research uncovering additional therapies on the horizon.

Tags: hepatitis c, liver, transplant, cancer, video
What do you think of this video?

Advancements in Treating Hepatitis C

Three to four million Americans are infected with Hepatitis C, a blood borne virus that affects the liver. Having become the most common blood-borne virus, the effect of Hepatitis C on the liver has made it the number one reason for liver transplantation in the U.S., and is also responsible for the rising incidence of liver cancer. Fortunately, Hepatitis C is curable, thanks to recent therapeutic advancements. In this video, Dr. Paul Kwo—Gastroenterologist and Hepatologist at IU Health and Professor of Medicine at the Indiana University School of Medicine—highlights the effectiveness of new treatments available for Hepatitis C and speaks to the ongoing research uncovering additional therapies on the horizon.

What do you think of this video? print